Melanoma Combination Therapy of Cobimetinib and Atezolizumab in BRAFV600 Wild-Type Melanoma Patients Aug 29, 2023
Head & Neck Cancer,SCC (Squamous Cell Carcinoma),Skin Cancer Efficacy of Durvalumab and Tremelimumab for LA-HNSCC Aug 21, 2023
Melanoma,Skin Cancer Anti-LAG-3 Plus Anti-PD-1 Vs. Pembrolizumab in Pts With Completely Resected High-Risk Melanoma Aug 14, 2023
BCC (Basal Cell Carcinoma),SCC (Squamous Cell Carcinoma),Skin Cancer Intralesional T-VEC Induces Clinical Responses and Activates Immune Response in CBCL Lesions Aug 14, 2023
Melanoma,Skin Cancer Phase 3 Trial: Fianlimab + Cemiplimab vs. Pembrolizumab in High-Risk Melanoma Jul 31, 2023
Melanoma,Skin Cancer 1L Atezolizumab With Vemurafenib and Cobimetinib Improves OS in BRAFV600 Advanced Melanoma Jun 01, 2023
Melanoma,Skin Cancer NNT and NNH Utilized to Assess the Efficacy and Safety of Adjuvant Therapies in Melanoma Jun 01, 2023
